![Lung-MAP: A lung cancer precision medicine trial](/sites/default/files/styles/news_recent/public/news/2023-12/LungMap.Twitter%201.png?itok=8cEYIf7d)
Dec 1, 2023
Ten years on, Lung-MAP success demonstrates potential of public-private partnerships in clinical research
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-12/FrontLineHead.Blanke.2022-web-sized.png?itok=juP5DU-l)
Dec 1, 2023
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-11/FrontLineHead.Blanke.2022-web-sized_2.png?itok=qPg3UjcH)
Nov 24, 2023
![Lung-MAP: A lung cancer precision medicine trial](/sites/default/files/styles/news_recent/public/news/2023-11/LungMap.Twitter%201.png?itok=AcZXmtjt)
Nov 21, 2023
The Fall 2023 issue of the Lung-MAP Newsletter is now out!
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-11/FrontLineHead.Blanke.2022-web-sized_1.png?itok=mcTShROX)
Nov 17, 2023
![Clinical Cancer Research journal masthead](/sites/default/files/styles/news_recent/public/news/2023-11/press-card-S1314-Lerner-2-725x435.png?itok=d1ZxrHeQ)
Nov 15, 2023
RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer.
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-11/FrontLineHead.Blanke.2022-web-sized_0.png?itok=RLvBz3Nu)
Nov 10, 2023
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-11/FrontLineHead.Blanke.2022-web-sized.png?itok=TAAjf5ik)
Nov 3, 2023